Cello World Q1 FY27: consolidated PAT down 9% YoY on soft demand, revenue nearly flat

Cello World's consolidated Q1 FY27 revenue came in at ₹526.72 Cr, down 0.4% YoY (against a restated ₹529.01 Cr base) and down 19.4% QoQ off a seasonally strong Q4. Consolidated PAT was ₹73.40 Cr, down 9.0% YoY versus the filing's restated Q1 FY26 comparative of ₹80.65 Cr (note: this restated comparative is a large swing from what our records had captured for that quarter, tied to the WimPlast/CCPPL scheme becoming effective retrospectively) and down 18.6% QoQ. Standalone tells a sharper story — revenue fell 8.8% YoY to ₹257.15 Cr and PAT fell 28.1% YoY to ₹16.86 Cr — a materially wider decline than the consolidated print, reflecting that standalone captures only the parent trading entity while the group's manufacturing subsidiaries (steelware, glassware, writing instruments) cushion the consolidated numbers; consolidated is the primary basis here given the scale gap.

Management's own framing (in its press release) attributes the softness to "a challenging demand environment, elevated input costs, and a lower scale of steel bottle business due to non-availability of imported inventory" versus the year-ago quarter, while noting NPM of 13.9% and EBITDA margin of 22.2% — broadly consistent with our computed consolidated NPM of 13.94%, though down from a restated 15.25% NPM a year ago, i.e. YoY margin compression even as absolute profitability stays healthy. Management says in-house manufacturing of the steel bottles has already started and "should gradually scale up in the coming quarters," directly naming the fix for the volume shortfall.

The stock went into the print at ₹373.15, up 4.1% over the past month of trading.

Against the prior concall's FY27 guidance (10-12% full-year revenue growth, 2-2.5pp EBITDA margin improvement, steelware/glassware scale-up, writing instruments toward ₹500 Cr), Q1's -0.4% YoY revenue is well off the pace needed for double-digit full-year growth, so this quarter reads as a miss against that trajectory — though external commentary ahead of results had flagged Q1 as a likely soft patch as the market absorbed 12-20% MRP increases, so the softness wasn't unheralded. No formal Street consensus for this specific quarter's revenue/PAT could be confirmed via search, so vsStreet is marked unknown rather than guessed. Concurrently, the company confirmed no deviation in utilisation of its ₹738 Cr QIP funds for the quarter (Annexure B) and denied media reports of Bain Capital stake-buy talks a day before results — neither is a numbers-moving item but both were live investor-facing developments this week.